IPO Issue Details
Issue Price / Price Band₹84 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,600 Shares per Lot
Total Issue Size70,00,000 shares (aggregating up to ₹58.80 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenFri, 25 Jul 2025
Subscription CloseTue, 29 Jul 2025
Anchor AllotmentThu, 24 Jul 2025
Basis of AllotmentWed, 30 Jul 2025
Initiation of RefundsThu, 31 Jul 2025
Credit of Shares to DematThu, 31 Jul 2025
Listing DateFri, 01 Aug 2025
UPI Mandate Deadline2025-07-29
Application & Investment Details
Retail — Min (2 Lots)₹2,68,800 — 3200 shares
Retail — Max (13 Lots)₹1,747,200 (13 Lots)
HNI — Min (3 Lots)₹4,03,200 — 4800 shares
EPS (Pre-IPO)₹5.91
EPS (Post-IPO)₹4.25
P/E Ratio (Pre-IPO)14.21x
P/E Ratio (Post-IPO)19.77x
Net Offer to Public66,46,400 shares (aggregating up to ₹55.83 Cr)
Reserved for Market Maker3,53,600 shares (aggregating up to ₹2.97 Cr)
Pre-IPO Promoter Holding1,78,70,000 shares
Post-IPO Promoter Holding2,48,70,000 shares
About Patel Chem Specialities Ltd.
Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting pharmaceutical excipients and specialty chemicals.The company manufactures various essential chemicals used in pharmaceuticals, food, cosmetics, and industrial applications, serving as binders, disintegrants, thickeners, stabilizers, and gelling agents across industries.The company’s manufacturing facilities in Vatva, Ahmedabad, and Talod, Himmatnagar, follow strict quality control standards, ensuring bulk production of chemicals that meet international certifications like US-DMF and GMP.The company’s manufacturing facility covers 7,000 square yards, with a capacity of over 7,200 MT annually for pharmaceutical excipients, featuring departments for storage, production, R&D, quality control, packaging, and warehousing.The company has expanded globally, serving East Asia, Europe, the Middle East, North America, and Southeast Asia, delivering high-quality products that meet international standards to lead the chemical industry.Product Portfolio:Rheollose® (Sodium Carboxymethyl Cellulose): A cellulose gum used as a thickening and stabilizing agent in various applications.Disolwell® (Croscarmellose Sodium): A super disintegrant used in oral pharmaceutical formulations to enhance tablet disintegration.Swellcal® (Calcium Carboxymethyl Cellulose): Used as a super disintegrant in pharmaceutical applications.AmyloTab™ (Pregelatinized Starch): Used in tablet formulations to aid in the disintegration and dissolution processes.As of March 31, 2025, the company has a total strength of 136 employees.
Objects of the Issue
Patel Chem Specialities Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Funding capital expenditure requirement of the Company
43.15
2
2 General corporate purposes
8.40
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,78,70,000 shares
Post-IPO Promoter Holding
2,48,70,000 shares